4.6 Article

Simultaneous expression of steroid sulfatase and androgen receptor reduced overall survival of patients with epithelial ovarian tumors

Journal

JOURNAL OF OVARIAN RESEARCH
Volume 14, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s13048-021-00840-x

Keywords

Epithelial ovarian tumor; Ovarian cancer; Steroid sulfatase; Androgens; Androgen receptor

Funding

  1. DGAPA-PAPIIT [IN221219, IN218120]
  2. CONACYT doctoral fellowship

Ask authors/readers for more resources

The study found that the co-expression of STS and AR in ovarian tumors is associated with poor prognosis, suggesting that testosterone via its receptor promotes tumor growth and progression. This highlights the importance of researching the molecular mechanisms involved in ovarian carcinogenesis and identifying new prognostic markers for improving patient outcomes.
Background Ovarian cancer is usually diagnosed at an advanced stage due to its early asymptomatic course and late-stage non-specific symptoms. This highlights the importance of researching the molecular mechanisms involved in ovarian carcinogenesis as well as the discovery of novel prognostic markers that could help improve the survival outcome of patients. The aim of this study was to evaluate the expression of the steroid sulfatase (STS) in 154 samples of primary ovarian tumors. This protein is crucial in the intracellular conversion of sulfated steroid hormones to active steroid hormones. The presence of STS, 3 beta-HSD, and 17 beta-HSD1 result in the production of testosterone which act through the androgen receptor (AR) in the tumor cell. The presence of STS and AR in epithelial ovarian tumors and their association to the overall survival of patients was evaluated using Kaplan-Meier and Cox regression analyses. Results Immunoreactivity for STS was detected in 65% of the tumors and no association was observed with histological subtypes and clinical stages of the tumor. The STS expression in the tumors exhibiting immunoreactive AR resulted in a reduced survival (log-rank test, p = 0.032) and a risk factor in univariate and multivariate analysis, HR = 3.46, CI95% 1.00-11.92, p = 0.049 and HR = 5.92, CI95% 1.34-26.09, p = 0.019, respectively. Conclusions These findings suggest that the intracellular synthesis of testosterone acting through its receptor can promote tumor growth and progression. Moreover, the simultaneous expression of STS and AR constitutes an independent predictor of poor prognosis in epithelial ovarian tumors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available